CPT code 87534 designates a laboratory molecular diagnostic assay for human immunodeficiency virus type 1 (HIV‑1) performed with a direct probe technique. This code captures a targeted nucleic acid detection method used to identify HIV‑1 in clinical specimens and supports diagnosis, infection confirmation, and patient management decisions. Nationally, accurate coding for HIV diagnostic tests is important for surveillance, public health reporting, and appropriate laboratory reimbursement.

Key payers considered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on the clinical purpose of the test, typical sites of service, and the billing context for laboratory molecular diagnostics. The publication outlines benchmarks and payer coverage considerations, summarizes clinical relevance for HIV‑1 detection, and highlights where policy updates or coding clarifications can affect lab billing and claims processing.

The content is intended for a national audience of billing professionals, laboratory administrators, and health policy analysts seeking a clear description of the code, its clinical role, and implications for payer interactions and claims administration. Data not available in the input will be noted where applicable.